Ghana's hemp revolution: NACOC and CSIR join forces to unlock medicinal and industrial cannabis potential

Ghana is moving decisively into the regulated cannabis sector with a landmark partnership between the Narcotics Control Commission (NACOC) and the Council for Scientific and Industrial Research (CSIR), signalling the country's commitment to harnessing hemp for economic gain while maintaining strict public safety controls.

The collaboration centres on research and sustainable cultivation of cannabis with a tetrahydrocannabinol (THC) content capped at 0.3 per cent—the international standard for industrial hemp—alongside development of medicinal applications. NACOC Director-General Major General Maxwell Obuba Mantey emphasised that Ghana aims to extract maximum economic, industrial and medicinal benefits from the regulated cannabis sector without compromising public health or safety.

Practical collaboration: From farms to laboratories

The partnership will operate across multiple fronts. NACOC and CSIR will establish model greenhouse farms to demonstrate best practices in low-THC cannabis cultivation, conduct comprehensive soil testing to identify optimal growing conditions across Ghana's geography, and develop seedling production capabilities suited to the 0.3 per cent THC threshold.

Laboratory work forms another cornerstone. The institutions will examine hemp's chemical properties, assess potential medicinal applications, and evaluate industrial derivatives. Farm traceability systems—crucial for regulatory compliance and preventing diversion into illicit markets—will be developed with CSIR's technical support to monitor licensed cultivation from seed to final product.

Technical guidance for farmers, regulators and stakeholders across the entire cannabis value chain will be provided by the partnership, strengthening local capacity in this emerging sector.

Industrial and medicinal opportunities for Ghana

CSIR-Institute of Industrial Research Director Dr Francis Boateng Agyeinim identified significant commercial potential. Ghana's soils are suited to producing hemp with high fibre content, opening doors to diverse applications: hemp fibre could replace plastic in packaging, feature in sanitary product manufacturing, and serve other industrial uses currently under exploration.

The medicinal dimension is equally significant. Properly regulated, low-THC cannabis products offer therapeutic applications that Ghana can develop locally, potentially positioning the country as a regional supplier of pharmaceutical-grade hemp derivatives.

Why it matters for Ghana

This partnership reflects a global shift toward cannabis legalisation and represents Ghana's pragmatic response to an industry already developing informally across West Africa. Rather than prohibit, Ghana is choosing to regulate—a strategy that can generate tax revenue, create agricultural jobs, and attract investment while maintaining security.

The collaboration also underscores the importance of scientific evidence in policy-making. By anchoring the hemp industry in research and technical expertise from a reputable institution like CSIR, Ghana reduces risks of regulatory failure or public health compromise.

For Ghanaian farmers, this presents diversification opportunities in regions where traditional crops face climate pressure or market volatility. For manufacturers and exporters, access to domestically produced hemp fibre and medicinal extracts could support industrial competitiveness regionally and internationally.

The 0.3 per cent THC threshold and robust monitoring systems are designed to prevent the regulated sector from becoming a cover for high-THC drug production—a critical safeguard for community trust and international credibility as Ghana positions itself as a responsible, evidence-based regulator in an emerging global industry.